Chinese cancer drug developer Akeso banks on pharma tie-up in race with rivals amid record-setting Hong Kong IPO

Chinese cancer drugs developer Akeso is banking on a marketing tie-up with pharmaceutical major Sino Biopharmaceutical to catch up with competitors after a record-setting initial stock offering in …
( read original story …)

---